Investing

Stoke Therapeutics : STOK

STOK

Stock Data

$28.93

$0.35 (1.20%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Stoke Therapeutics Inc is a pioneering biopharmaceutical firm focused on developing innovative treatments for severe genetic diseases. With a unique approach using antisense oligonucleotides, the company aims to restore protein levels in patients. Its leading projects include STK-002 for autosomal dominant optic atrophy and STK-001 for Dravet syndrome, among others targeting central nervous system and eye diseases. Based in Bedford, Massachusetts, Stoke Therapeutics has formed a significant partnership with Acadia Pharmaceuticals to advance RNA-based medicines for rare neurodevelopmental conditions.

All Stoke Therapeutics Articles

3 Articles

Lee Jackson | Apr 27, 2023 at 8:51 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Albertsons, Alphabet, Apple, Coinbase, General Electric, McDonald’s, Microsoft, Tesla and More

Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General…

Chris Lange | Oct 24, 2022 at 8:58 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: AT&T, ADM, Chevron, FedEx, Intel, Meta, Qualcomm and More

Monday's top analyst upgrades and downgrades included AT&T, ADM, Chevron, FedEx, Intel, Meta, Qualcomm and more.

Chris Lange | Feb 10, 2021 at 12:33 PM EST

Barrick, Lyft, Nordstrom, Twitter and More Wednesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including in Barrick,…